Free Republic

Moderna stock more than doubled Wednesday after the biotechnology company and Merck announced that their personalized mRNA cancer vaccine significantly delayed the return and spread of melanoma in a late-stage clinical trial. The breakthrough could give Moderna its most important commercial opportunity since COVID-19, strengthen Merck’s dominant Keytruda franchise and open the door to an entirely new class of individualized cancer treatments. However, investors should recognize that the companies have released only topline results, while detailed efficacy data, regulatory decisions, manufacturing economics and overall-survival results remain outstanding.Moderna’s long-promised second act may finally be coming into focus.Shares of Moderna jumped approximately...

Shares of Merck (MRK) and Moderna (MRNA) spiked in the premarket on Wednesday after the companies said that their jointly developed messenger RNA-based cancer therapy, intismeran autogene, succeeded in a late-stage trial for patients with melanoma, a type of skin cancer. The Phase 3 INTerpath-001 trial was designed to evaluate intismeran in combination with Merck's (MRK) blockbuster anti-PD-1 therapy Keytruda in more than 1,100 patients with stage IIB-IV melanoma whose cancer has been completely resected. According to its topline data, INTerpath-001 met its primary endpoint of recurrence-free survival and a secondary endpoint of distant metastasis-free survival, marking the first late-stage...

Senators Ron Johnson and Rand Paul on Monday released the first batch of text messages from Dr. Fauci’s Covid-era iPhone. The text messages revealed that Fauci privately knew that the Covid vaccine caused miscarriages in pregnant women. Fauci covered up the data that revealed an 82% miscarriage rate in women vaccinated during the first trimester. Dr. Anthony Fauci privately discussed concerns about COVID-19 mRNA vaccines for pregnant women in January 2021, including questions about fever after a second dose and a theoretical risk of miscarriage during the first trimester, according to newly released text messages. The exchange involved Fauci, then-Centers...

The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said. “Flu remains a significant public health challenge, and mFLUSIVA provides an important new option for America’s seniors,” Moderna CEO Stephane Bancel said in a statement. “This approval also reflects the ongoing potential of our mRNA platform to help address important public health challenges through continued scientific innovation.” The new vaccine was found to be about 27% more effective during the 2024–25 respiratory virus season than standard flu shots in Moderna’s study, which enrolled over 40,000 adults...

The Food and Drug Administration on Wednesday approved the U.S.’ first flu shot that uses mRNA technology: mFlusiva, from drugmaker Moderna. The FDA granted approval for two age groups, adults 50 to 65 and adults 65 and up, on the condition that Moderna run an additional clinical trial in the older group, the company said in a release. In a late-stage trial, mFlusiva was found to be about 27% more effective than a standard flu shot. Many scientists and public health experts have touted the idea of an mRNA-based flu vaccine, which uses the same messenger RNA platform as the...

Recommendation could pave the way for approval of the mRNA vaccine in adults 50 and upAn FDA advisory panel on Thursday unanimously endorsed the use of Moderna's trivalent flu vaccine candidate, which uses mRNA technology that's come under fire from the nation's top health official. In two 9-0 votes, the Vaccines and Related Biological Products Advisory Committee said the benefits of the mRNA vaccine outweigh its risks for preventing the flu in adults 50 to 64 years and in those 65 and up. "I do believe the data presented support that the benefits of the vaccine in both age groups...

June 1 (Reuters) - Global health organisation CEPI will give roughly $60 million to Moderna (MRNA.O), opens new tab and two other groups to accelerate the development of shots ​against Ebola Bundibugyo, the deadly virus that has swept through eastern Democratic Republic of Congo. The Coalition for Epidemic Preparedness Innovations was one of the ‌early investors that helped to develop a vaccine at the height of the COVID-19 pandemic. Richard Hatchett, head of CEPI, told Reuters on Monday it was possible to get Ebola Bundibugyo (BDBV) vaccines ready for trials within a couple of months. There are currently no approved...

The recent outbreak aboard the MV Hondius cruise ship has renewed attention on the efforts to develop a vaccine for the virus. … Work on the vaccine began 15 years ago by the founders of EnsiliTech, a biotech company based in the U.K. "We looked at hantavirus and saw it was pretty neglected," said Matt Slade, a company co-founder and its chief of staff. "There wasn't really any work in the sector." The EnsiliTech vaccine, which is being developed to fight the virus, uses messenger RNA technology, similar to that used in COVID-19 shots. The hantaan virus, common in East...

Feb 27 (Reuters) - Europe's medicines regulator recommended approval for Moderna's COVID and flu combination vaccine on Friday, putting it on track to become the ‌first single shot to protect people aged 50 and older against both illnesses. Currently ‌people need two separate shots to protect them against COVID-19 and influenza and the vaccines are updated regularly to ​match the viral strains in circulation. Moderna is banking on the COVID-flu combination shot and also an mRNA-based flu shot to help it return to revenue growth as demand for COVID vaccines has collapsed in the years after the pandemic. It hopes...

Bayer's (BAYGn.DE), opens new tab Monsanto sued COVID-19 vaccine makers Pfizer (PFE.N), opens new tab, BioNTech (22UAy.DE), opens new tab and Moderna (MRNA.O), opens new tab in Delaware federal court on Tuesday for allegedly misusing its messenger RNA technology in manufacturing their vaccines, a Bayer spokesperson confirmed.

[H/T Mewzilla]https://x.com/disclosetv/status/1964337164537180601 Disclose.tv @disclosetvNOW - MAHA Chief Medical Advisor: "Not a single person should of been injected with this, what is more better described as a gene therapy than as a vaccine... highly likely the Covid vaccines have been a significant factor in the cancer of members of the Royal family."September 6, 2025~~~~TRANSCRIPT OF VIDEO BEGINS~~~~If there is no harm, you could make the case, 'let's give it to everybody' and we'll save some lives. But unfortunately, nothing could be further from the truth. A re-analysis of the data of Pfizer and Moderna's trials published in the Journal of Vaccine...

You’re living in a Sci-Fi movie, they just want you too dazed and confused to know it. Over the past four years or so, since the advent of the COVID-19 bioweapon injections, numerous people across the world have been flabbergasted. The refrains are often the same. Never seen anything like it. Thirty years of practice and this is a first. Can’t explain it. Don’t understand it. Can’t believe what I’m actually seeing. Personally, I’ve felt the same way. At first, you’re ridiculed for even bringing it up, then people begrudgingly accept that it might exist, but they minimize it. They...

“I wear no tin-foil hat. I’m asking for the ability to officially document what happened to me.” Three and a half years ago I contracted Guillain Barre Syndrome after getting the Jansen-J&J viral vector vaccine for COVID-19. The neurological disorder has left me hobbled by numb hands and feet, staggering around imbalanced, and battling debilitating fatigue. It has also left me, and thousands of others, feeling ignored and unheard by the government and the public health establishment. I wrote about the experience in 2021 in The Boston Globe, after the FDA attached a warning to the J&J shot, citing an...

Robert F. Kennedy Jr. just made a stunning move inside the Department of Health and Human Services, terminating two top officials. Heather Flick Melanson, his Chief of Staff, and Hannah Anderson, Deputy Chief of Staff for Policy, are OUT. According to ABC News, the dismissals were sudden

July 10 (Reuters) - The U.S. Food and Drug Administration has granted full approval for Moderna's (MRNA.O), opens new tab COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday. The shot was previously available for pediatric populations under emergency use authorization. Moderna expects to make its updated vaccine available for eligible U.S. population for the 2025-26 respiratory virus season. Health secretary Robert F. Kennedy Jr. had in May said the U.S. has stopped recommending routine COVID-19 vaccinations for healthy children and healthy pregnant women....

Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and the company’s separate combination flu and Covid jab. Moderna in May voluntarily withdrew an application seeking approval of its combination shot targeting Covid-19 and influenza, saying it had plans to resubmit it with efficacy data from the phase three trial on its stand-alone flu vaccine. That decision came after discussions with the Food and Drug Administration, which is grappling with a massive overhaul under Health and Human Services Secretary...

Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283), a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention"The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19," said Stéphane Bancel, Chief Executive Officer of Moderna. "COVID-19 remains a serious public health threat, with more than 47,000...

Moderna said on Wednesday it had withdrawn an application seeking approval for its flu and Covid combination vaccine candidate after discussions with the US Food and Drug Administration. The company said it would resubmit the application later this year with vaccine efficacy data from a late-stage trial of its experimental seasonal influenza vaccine, which it expects to report this summer. The decision comes a day after the US FDA said it would require new clinical trials for approval of annual Covid-19 boosters for healthy people under 65 years old. Shares of the company have been battered by declining Covid revenue...

For years, health authorities assured the public that mRNA COVID-19 vaccines were a temporary intervention — delivering a brief genetic message before harmlessly fading away. But a shocking new study published in Nature reveals a far darker reality: These shots don’t just deliver instructions — they reprogram the body to extend their lifespan, forcing cells to produce spike protein far longer than disclosed. The bombshell findings expose a hidden layer of genetic manipulation, raising urgent questions about long-term risks, informed consent, and the true cost of Big Pharma’s rushed “miracle” technology.

Dr. Joseph Ladapo, Florida’s top health official, co-authored the preprint paper.. Florida adults who received Pfizer’s COVID-19 vaccine were more likely to die following vaccination than Moderna COVID-19 recipients, according to a new preprint study that was co-authored by Florida’s top health official. Dr. Joseph Ladapo, Florida’s surgeon general, and other researchers identified nearly 9.2 million Florida adults not living in institutions who received at least two doses of the Pfizer or Moderna vaccine less than six weeks apart between Dec. 18, 2020, and Aug. 31, 2021. They narrowed the group to nearly 1.5 million, half who received Pfizer’s vaccine...